Christopher Lazzara joins Bravado Health's board of directors
|
WEST PALM BEACH, Fla., Oct. 15, 2019 /PRNewswire/ -- Bravado Health today announced that Christopher Lazzara has joined the company's board of directors. Lazzara was CEO of Neptune Research LLC until their recent merger with Clock Spring. He is now a board member of the combined Clockspring-NRI corporation.
"Chris is a highly respected CEO and well-known leader in composite repair technology," said Bravado Health CEO David Dietze. "We look forward to his insight and counsel as a member of Bravado Health's board." "I am excited to join the Bravado Health team," said Lazzara. "I realize the great opportunity in front of us to deliver cutting-edge technology and help lower the cost of healthcare in the U.S." Lazzara is chairman of NRI and a member of the Clockspring-NRI board of directors. He joined NRI as a sales manager in 2000, and has served as NRI's chief executive officer since 2009. Lazzara currently serves on the board of directors of NRI and Aquaco. Under his leadership, NRI appeared in the list of Top 50 Florida Companies to Watch in 2011 and was awarded Manufacturer of the Year for Florida in 2015. He is the holder of several United States patents. Lazzara received his Bachelor of Science degree from Florida State University. About Bravado Health Contact
SOURCE Bravado Health |
View original content to download multimedia: